Urine testing for norcodeine, norhydrocodone, and noroxycodone facilitates interpretation and reduces false negatives
Authors:
- 29 December 2009
- journal article
- Published by Elsevier in Forensic Science International
- Vol. 198 (1-3) , 58-61
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Urine Toxicology Testing in Chronic Pain ManagementPostgraduate Medicine, 2009
- Urine Drug Testing of Chronic Pain Patients: Licit and Illicit Drug PatternsJournal of Analytical Toxicology, 2008
- Prescription Drug Abuse Rises GloballyJAMA, 2007
- Opioid Prescriptions SoarJAMA, 2007
- Universal Precautions in Pain Medicine: A Rational Approach to the Treatment of Chronic PainPain Medicine, 2005
- Urine drug testing in pain medicineJournal of Pain and Symptom Management, 2004
- Role of Urine Toxicology Testing in the Management of Chronic Opioid TherapyThe Clinical Journal of Pain, 2002
- Forensic Drug Testing for Opiates. VI. Urine Testing for Hydromorphone, Hydrocodone, Oxymorphone, and Oxycodone with Commercial Opiate Immunoassays and Gas Chromatography-Mass SpectrometryJournal of Analytical Toxicology, 1995
- CYP2D6 phenotype determines the metabolic conversion of hydrocodone to hydromorphoneClinical Pharmacology & Therapeutics, 1993
- Forensic Drug Testing for Opiates, III. Urinary Excretion Rates of Morphine and Codeine Following Codeine AdministrationJournal of Analytical Toxicology, 1991